Therefore, we hypothesized that CUR reactivated the ARHGEF12 TSG to block colon cancer cell proliferation and migration via cancer pathways, whereas CUR might exert an inhibitory effect on invasion and migration by blocking the binding of ARHGEF12 to RhoA. The gene discussed is ARHGEF12; the disease is malignant colon neoplasm.